Clinical Trial Update: A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. [Phase 4]

View source ↗

Summary

Phase 4 study update evaluating efficacy and safety of apremilast in moderate plaque psoriasis; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Parapsoriasis | Phase 4 | Status: COMPLETED | Results posted: 2017-06-06